Education
About Us
Working with TipRanks
Follow Us
Kromek Group PLC (GB:KMK)
LSE:KMK
KMK Stock Chart & Stats
8.50p
-0.29p(-5.84%)
At close: 4:00 PM EST
8.50p
-0.29p(-5.84%)
Day’s Range― - ―
52-Week Range4.70p - 13.00p
Previous CloseN/A
Volume321.93K
Average Volume (3M)3.19M
Market Cap
£72.06M
Enterprise Value78.62M
Total Cash (Recent Filing)£1.25M
Total Debt (Recent Filing)£7.81M
Price to Earnings (P/E)5.7
Beta0.53
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding655,096,860
10 Day Avg. Volume2,321,691
30 Day Avg. Volume3,192,291
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.63
Price to Sales (P/S)1.23
P/FCF Ratio2.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained top-line expansion of ~66% indicates growing demand for Kromek's detectors and systems across its target markets. Durable revenue growth supports scale economies, funds R&D and product development, and improves bargaining power with suppliers and customers over the medium term.
High And Improving MarginsVery strong gross and expanding operating margins reflect efficient manufacturing and value capture from proprietary detector technology. Margin durability enhances free cash generation potential, creates room for reinvestment, and provides a competitive buffer versus lower-margin rivals in security and medical markets.
Prudent Balance Sheet, Low LeverageExtremely low leverage and a high equity base give Kromek financial flexibility to fund contract fulfilment, invest in product development, and absorb procurement timing volatility. A strong balance sheet reduces refinancing risk and supports pursuing strategic partnerships or selective M&A.
Bears Say
Negative Free Cash Flow GrowthNegative FCF growth indicates the company is not consistently converting operating performance into incremental free cash, which can constrain internal funding for capex, R&D or scaling. Over months, this raises reliance on external financing if growth and margin gains must be funded.
Contract And Program Timing RiskHeavy reliance on program-based sales and public-sector procurement creates lumpy, timing-sensitive revenue streams. This structural seasonality can amplify working capital swings, complicate capacity planning and create earnings volatility across 2–6 month horizons.
Limited Employee Base May Constrain ScaleA relatively small workforce can limit manufacturing throughput, program management and concurrent project delivery for large government or medical contracts. Over the medium term, constrained headcount raises execution risk when bidding for multiple or sizable defense and nuclear programs.
Kromek Group plc News
KMK FAQ
What was Kromek Group PLC’s price range in the past 12 months?
Kromek Group PLC lowest share price was 4.70p and its highest was 13.00p in the past 12 months.
What is Kromek Group PLC’s market cap?
Kromek Group PLC’s market cap is £72.06M.
When is Kromek Group PLC’s upcoming earnings report date?
Kromek Group PLC’s upcoming earnings report date is Jun 25, 2026 which is in 144 days.
How were Kromek Group PLC’s earnings last quarter?
Kromek Group PLC released its earnings results on Jan 20, 2026. The company reported 0.005p earnings per share for the quarter, beating the consensus estimate of N/A by 0.005p.
Is Kromek Group PLC overvalued?
According to Wall Street analysts Kromek Group PLC’s price is currently Overvalued.
Does Kromek Group PLC pay dividends?
Kromek Group PLC does not currently pay dividends.
What is Kromek Group PLC’s EPS estimate?
Kromek Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kromek Group PLC have?
Kromek Group PLC has 655,096,860 shares outstanding.
What happened to Kromek Group PLC’s price movement after its last earnings report?
Kromek Group PLC reported an EPS of 0.005p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.565%.
Which hedge fund is a major shareholder of Kromek Group PLC?
Currently, no hedge funds are holding shares in GB:KMK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kromek Group plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.19%
12-Months-Change
Fundamentals
Return on Equity
7.39%
Trailing 12-Months
Asset Growth
-3.83%
Trailing 12-Months
Company Description
Kromek Group PLC
Kromek Group plc (KMK) is a UK-based technology company that specializes in advanced radiation detection solutions. The company operates primarily in the sectors of security, medical imaging, and nuclear instrumentation. Kromek's core products include high-performance detectors and imaging systems that leverage its proprietary technology, particularly in the fields of gamma and X-ray detection. The company focuses on providing critical insights for applications such as airport security screening, medical diagnostics, and monitoring of nuclear facilities.
Technical Analysis
Gooch & Housego
―
Judges Scientific
―
TT Electronics
―
Windar Photonics
―
discoverIE Group plc
―
Options Prices
Currently, No data available
---